HOLOGIC, INC. (NASDAQ:HOLX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On May 15, 2017, the Board of Directors of the Hologic, Inc. (the
Company) elected Charles J. Dockendorff as a director of the
Company, effective immediately. Mr. Dockendorff was formerly the
executive vice president and chief financial officer of Covidien
plc.
Mr. Dockendorff, who will stand for election by stockholders at
the Companys 2018 Annual Meeting of Stockholders, has been
appointed to serve on the Audit and Finance Committee of the
Board of Directors. As a non-employee director of the Company,
Mr. Dockendorff will receive compensation as described in the
Director Compensation section of the Companys 2017 Proxy
Statement.
A copy of the Companys press release announcing the election of
Mr. Dockendorff is filed with this Current Report on Form 8-K as
Exhibit 99.1.
| Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits
| Exhibit Number | Description | |
| 99.1 | Press Release dated May 16, 2017. |
About HOLOGIC, INC. (NASDAQ:HOLX)
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems. HOLOGIC, INC. (NASDAQ:HOLX) Recent Trading Information
HOLOGIC, INC. (NASDAQ:HOLX) closed its last trading session up +0.20 at 43.44 with 4,185,482 shares trading hands.